Taiwan FDA registration 88fc1d7a54e192bd1b6899dde9bba79f

"Ruijian" influenza virus A&B antigen rapid test reagent (unsterilized)

TW: “銳鑑”流感病毒A＆B抗原快速檢驗試劑(未滅菌)

Taiwan·Risk Class 1·RAPIGEN INC.·Registered Jul 10, 2012 – Jul 10, 2017Cancelled

Registration details

Analysis ID: 88fc1d7a54e192bd1b6899dde9bba79f
Customs Code: DHA04401192606

Company information

Manufacturer: RAPIGEN INC.
Manufacturer Country: Korea, Republic of
Authorized Representative: JOLEX INTERNATIONAL CO., LTD.

Product details

Intended Use: Limited to the first level identification range of the Measures for the Administration of Medical Devices "Influenza Virus Serum Reagent (C.3330)".
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3330 流感病毒血清試劑
Import Information: import

Dates and status

Registration Date: Jul 10, 2012
Expiry Date: Jul 10, 2017
Cancellation Date: Jan 18, 2019

Cancellation information

Status: Logged out
Reason: 許可證已逾有效期

About this record

Access comprehensive regulatory information for "Ruijian" influenza virus A&B antigen rapid test reagent (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 88fc1d7a54e192bd1b6899dde9bba79f and manufactured by RAPIGEN INC.. The authorized representative in Taiwan is JOLEX INTERNATIONAL CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.